Soluble st2 as a marker for disease
OwnerYves Levyinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to materials and methods concerning the IL-1 receptor family protein ST2. Use of soluble ST2 as a marker for cardiovascular disease or disease outcome is provided, in particular as a marker of the risk of mortality.
Claims13
A method of predicting the risk of mortality of a HIV-infected subject comprising
- (i) determining the level of sST2 in a biological sample from said subject;
- and
- (ii) comparing said level of ST2 with a control level
- wherein a level of sST2 in the subject sample which is higher than that of the control is indicative of an increased risk of mortality.
A method of prognosis of cardiovascular disease in an HIV-infected subject, said method comprising:
- (i) determining the level of sST2 in a biological sample from said subject;
- and
- (ii) comparing said level of sST2 with a control level;
- wherein a level of sST2 in the subject sample which is higher than that of the control is indicative of a poor prognosis.
A method of monitoring the efficacy of treatment of a cardiovascular disease, said method comprising monitoring sST2 expression during the course of the treatment, wherein a reduction in sST2 level over the course of the treatment is indicative of the efficacy of the treatment.
Dependencies are inferred from the claim text.